premier sponsors: Lindquist & Vennum Manitoba
 
LifeScience Alley® Conference & Expo
DECEMBER 8
MINNEAPOLIS
MINNESOTA
 
Register Now!
 
gold bar

Seminar Descriptions      

Scroll down to view seminar descriptions and speakers, or click on the accompany "Details" button for more information on the topic.
SPONSOR SPONSOR SPONSOR SPONSOR SPONSOR SPONSOR SPONSOR
Canada Manitoba   Lindquist  
Therapeutics Diagnostics Health IT Market Development Finance International Talent & Management
  Session 1  |  10:15 - 11:45 a.m.
Medical Devices Needed for Regenerative Medicine
Details
Predictive & Personalized Diagnostics
Details
There’s an App for That*
Details
Global Growth Markets for New Therapies
Details
Strategic Growth in the New World Economy
Details
Regulatory Affairs in a Flat World
Details
Managing Tomorrow’s Workforce
Details
  Session 2  |  2:00 - 3:30 p.m.
Innovative Collaborations in Product Development
Details
Reimbursement & Market Adoption of Diagnostic Platforms
Details
Effectively Harnessing the Deluge of Data
Details
Using Social Media and Direct-to-Consumer Marketing in a Regulated Environment
Details
Navigating the Valley of Death — Accessing Capital from Diverse Sources
Details
Care Goes Global
Details
Game Changers of the Future — The New Class of Innovators
Details
 
 
  Session 1  |  10:15 - 11:45 a.m.
Therapeutics
Session 1:

Medical Devices Needed for Regenerative Medicine

Experts in the field of cardiology, neurology and orthopedics will discuss current and future applications of regenerative medicine. In addition, they will address the challenges of delivering stem cells and tissues with examples of how the device industry plays a critical role in combination products. Beyond the science and engineering, they'll consider regulatory and reimbursement issues facing these therapies as well as the challenges of getting them to market.

Diagnostics
Session 1:

Predictive & Personalized Diagnostics
As medicine moves closer to a predictive, preventive and  personalized model, gene-based diagnostics, biomarkers and algorithms are being used to help identify which patients are likely to benefit most from a given therapy, whether it is a medical device, biologic or pharmaceutical.  Learn what's on the horizon in predictive tools and how they will affect the development and sales of devices, drugs & other therapies.

Health IT
Session 1:

There’s an App
for That
*
Mobile health applications are rapidly changing how care is delivered. In this session, you'll hear from companies who have developed exciting new patient-centered applications and those who interface on both the health care and wellness side. You'll also hear predictions for the future of mobile health applications, get a sense of how these tools are likely to fit within HIPAA and gain an understanding of what it takes to bring a new app to market.

*”There’s an App for that” is a trademark of Apple, Inc.
Market Development
Session 1:

Global Growth Markets for New Therapies
International marketing is not just the domain of global giants. Emerging life science companies can expand their markets abroad with the right approaches and networks. Experienced international market specialists will share insights on the hot countries for new products and will address the challenges in establishing an OUS distribution system.

Finance
Session 1:
Strategic Growth in the New World Economy

Established as well as mid-size and emerging companies need to understand what future growth will look like through strategic partnerships, licensing deals, mergers and acquisitions and investments around the globe. Gain insights from industry players and advisors who have successfully implemented investment strategies in countries such as India, Brazil and Japan. Learn what it takes to navigate challenging government, cultural and marketplace barriers.

International
Session 1:

Regulatory Affairs
in a Flat World


Given the increasing regulatory barriers in the U.S., what countries are emerging as effective sites for clinical trials and regulatory approval?  How are changing OUS regulatory structures affecting your regulatory pathway? This session will consider the risks and benefits of regulatory environments in less well known regions, such as China, India and South America, and address the prospects for successful FDA data submissions.

Talent & Management
Session 1:

Managing Tomorrow’s Workforce

Tomorrow’s leaders must adapt to managing a virtual and multi-generational workforce, keeping their teams connected to both the needs of their industry and the missions of their organizations. How can you support the transfer of knowledge and maintain your leadership in this New World business model? Learn how to maximize the benefits and work around the obstacles when managing the team of the future.
 
 Session 2  |  2:00 - 3:30 p.m.
Therapeutics
Session 2:

Innovative Collaborations in Product Development
This session will explore the value of partnerships in new drug and device product development. Fast-tracked and virtual companies rely on partnerships with design and manufacturing firms, university-industry relationships, strategic alliances between large and small companies and collaborations between physicians and engineers — all aimed at adding greater value to the patient and other stakeholders in the health ecosystem. What will the partnerships of the future look like?

Diagnostics
Session 2:

Reimbursement & Market Adoption of Diagnostic Platforms


With health care spending on the rise, the need for game-changing technologies that deliver quality care and radically lower costs has never been greater. This is where diagnostic platforms make a compelling case, integrating biomarkers, sensors, microfluidics, software, hardware, bioinformatics and more.  Who will drive the adoption and reimbursement of these tools? What are the implications for your product and market development?

Health IT
Session 2:

Effectively Harnessing the Deluge of Data
One of the most pressing issues of our time is the explosion of health information and the need for integration. What can manufacturers, clinical decision-makers, health plans and patients learn from bioinformatics and health records data? What value can be derived in a comparative effectiveness research context? How can cloud computing and storage be done securely? This session will also explore what new companies and careers are likely to form around this emerging industry.
Market Development
Session 2:

Using Social Media and Direct-to-Consumer Marketing in a Regulated Environment

Beyond Facebook, LinkedIn and Twitter, social media plays an increasingly important role in the life sciences. It's critical to understand both the opportunities as well as potential barriers in marketing your products and services to purchasers and end-users. How will the FDA weigh in on industry's use of social media? What are likely to emerge as best practices in this domain? 

Finance
Session 2:

Navigating the Valley of Death — Accessing Capital from Diverse Sources

The funding landscape for life science start-ups is changing dramatically in these capital-scarce times.  In this session, the audience will engage with a diverse group of funders to identify various traditional and non-traditional investment sources to bridge the Valley of Death funding gap. Discussion will focus on what value proposition is likely to attract various forms of early stage investment and what money is available, where.

International
Session 2:

Care Goes Global


Medical Tourism is revolutionizing health care in developed nations such as the U.S., with more patients going abroad,or even traveling to domestic centers of excellence, in search of expertise and value. This session will open your eyes to "hot spots" around the globe that are already creating competition for local health care providers, while potentially opening up new markets for medical products. What are the implications of this growing trend?

Talent & Management
Session 2:

Game Changers of the Future — The New Class of Innovators

Large companies may have the budgets, but do they have the fertile cultures needed to discover and incubate the next breakthroughs?  Where does your expertise reside internally and how do you gather it for optimal results? What value do smaller companies, entrepreneurs and external partners (that may not even be in your industry) bring to the equation? Learn how to identify, inspire and grow the new class of innovators to transform your work or business.

bar
 
"));